# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-113149
Filing Date
2024-12-27
Accepted
2024-12-27 17:00:41
Documents
71
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0225656-10k_citius.htm iXBRL | 10-K | 1376710
2 | DESCRIPTION OF COMMON STOCK | ea022565601ex4-22_citius.htm | EX-4.22 | 17242
3 | INSIDER TRADING POLICY | ea022565601ex19-1_citius.htm | EX-19.1 | 37106
4 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ea022565601ex23-1_citius.htm | EX-23.1 | 1790
5 | CERTIFICATION | ea022565601ex31-1_citius.htm | EX-31.1 | 9665
6 | CERTIFICATION | ea022565601ex31-2_citius.htm | EX-31.2 | 10032
7 | CERTIFICATION | ea022565601ex32-1_citius.htm | EX-32.1 | 4497
| Complete submission text file | 0001213900-24-113149.txt |  | 6073292

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | ctxr-20240930.xsd | EX-101.SCH | 52432
9 | XBRL CALCULATION FILE | ctxr-20240930_cal.xml | EX-101.CAL | 40709
10 | XBRL DEFINITION FILE | ctxr-20240930_def.xml | EX-101.DEF | 262162
11 | XBRL LABEL FILE | ctxr-20240930_lab.xml | EX-101.LAB | 490654
12 | XBRL PRESENTATION FILE | ctxr-20240930_pre.xml | EX-101.PRE | 275087
73 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0225656-10k_citius_htm.xml | XML | 520148

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-38174 | Film No.: 241586207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)